ASTM international workshop on standards and measurements for tissue engineering scaffolds

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 103, Issue 5, 2015, Pages 949-959

  Simon, Carl G ^a   Yaszemski, Michael J ^b   Ratcliffe, Anthony ^c   Tomlins, Paul ^d   Luginbuehl, Reto ^e   Tesk, John A ^f  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b MAYO CLINIC   (United States)

^c Synthasome Inc   (United States)

^d European Standards Consultant   (United Kingdom)

^e RMS Foundation   (Switzerland)

^f Biomedical Materials and Devices Consulting   (United States)

Author keywords

ASTM International; documentary standards; reference materials; tissue scaffold; workshop report

Indexed keywords

BIOMECHANICS; CHARACTERIZATION; MECHANICAL PROPERTIES; SCAFFOLDS (BIOLOGY); TESTING; TISSUE;

ASTM INTERNATIONAL; BIOLOGICAL CHARACTERIZATION; CELL-MATERIAL INTERACTION; MEASUREMENT TRACEABILITY; REFERENCE MATERIAL; TISSUE ENGINEERING SCAFFOLD; TISSUE SCAFFOLDS; WORKSHOP REPORT;

STANDARDS;

ARTICLE; DEGRADATION; DRUG RELEASE; HUMAN; IN VITRO STUDY; INSTRUMENT STERILIZATION; MEASUREMENT; MICROTECHNOLOGY; NONHUMAN; STANDARD; TISSUE ENGINEERING; TISSUE SCAFFOLD; WORKSHOP; ANIMAL; EDUCATION; ORGANIZATION; PROCEDURES; STANDARDS;

ANIMALS; CONGRESSES AS TOPIC; EDUCATION; HUMANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84931955170     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33286     Document Type: Article

References (66)

1. Plant AL, Horowitz E,. Symposium on metrology and standards for cell signaling: Impact on tissue engineering, National Institute for Standards and Technology, October 14-15, 2003. Tissue Eng 2005; 11: 985-990.
2. Russell AJ,. Standardized experimental procedures in tissue engineering: Cure or curse. Tissue Eng 2005; 11: vii-vix.
3. U.S.Food and Drug Administration. Guidance for Industry and FDA Staff: Frequently Asked Questions on Recognition of Consensus Standards. White Oak, MD: FDA; 2007. Available from URL: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm074973.htm. Accessed on September 6, 2014.
4. Messenger MP, Tomlins PE,. Regenerative medicine: a snapshot of the current regulatory environment and standards. Adv Healthcare Mater 2011; 23: H10-H17.
5. Leitner E, Bischoff P,. setting standards for technologies in regenerative medicine. Biomed Tech (Berl) 2012; 57: 1051-1054.
6. American Academy of Orthopaedic Surgeons. Position Statement: Consensus Standards for Medical Devices. Rosemont, IL: AAOS. 2013. Available from URL: http://www.aaos.org/about/papers/position/1169.asp. Accessed on September 6, 2014.
7. Tomlins P,. Chapter 6: Standards in cell and tissue engineering. In:, Salih V, editor. Standardisation in Cell and Tissue Engineering. Cambridge, UK: Woodhead International Limited; 2013. pp 107-23.
8. Ioannidis JP,. Why most published research findings are false. PLoS Med 2005; 2: 696-701.
9. Coombes KR, Wang J, Baggerly KA,. Microarrays: Retracing steps. Nat Med 2007; 13: 1276-1277.
10. Freedman DH,. Lies, Damned Lies and Medical Science. The Atlantic, November 4, 2010.
11. Lehrer J,. The Truth Wears Off: Is There Something Wrong with the Scientific Method? The New Yorker, December 13, 2010.
12. Prinz F, Schlange T, Asadullah K,. Believe it or not: How much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011; 10: 712-713.
13. Begley CG, Ellis LM,. Drug development: Raise standards for preclinical cancer research. Nature 2012; 483; 531-533.
14. Global Biological Standards Institute. The Case for Standards in Life Science Research: Seizing Opportunities at a Time of Critical Need. Washington, DC: GBSI. 2013. Available from URL: http://gbsi.org/CaseForStandards.
15. Plant AL, Parker GC,. Translating stem cell research from the bench to the clinic: a need for better quality data. Stem Cells Dev 2013: 22: 2457-2458.
16. Wadman M,. NIH mulls rules for validating key results. Nature 2013; 500: 14-16.
17. Alliance for Regenerative Medicine. Pharma and Biotech Survey. Washington, DC: ARM. 2014. Available from URL: http://allian cerm.org/sites/default/files/ARM-Pharma-SurveyRept-Mar2014-e.pdf. Accessed on September 6, 2014.
18. The Science Exchange. The Reproducibility Initiative. 2013. Available from URL: https://www.scienceexchange.com/reproducibility. Accessed on September 6, 2014.
19. ASTM Standard F2312-11. Standard Terminology Relating to Tissue Engineered Medical Products. West Conshocken, PA: ASTM International; 2011.
20. Makower J, Meer A, Denend L,. FDA Impact on U.S. medical technology innovation: A survey of over 200 medical technology companies.In:, Coopers LLP, editor. Pricewaterhouse. 2010. Stanford Univeristy, Stanford, CA, Available from URL: http://nvcaccess.nvca.org/index.php/topics/public-policy/155-fda-impact-on-innovation-study-out-today.html. Accessed on September 6, 2014.
21. ASTM Standard F2739-08. Standard Guide for Quantitating Cell Viability within Biomaterial Scaffolds. West Conshocken, PA: ASTM International; 2008.
22. ASTM Standard F2450-10. Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue-Engineered Medical Products. West Conshocken, PA: ASTM International; 2010.
23. ASTM Standard F2315-11. Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels. West Conshocken, PA: ASTM International; 2011.
24. ASTM Standard F2883-11. Standard Guide for Characterization of Ceramic and Mineral Based Scaffolds used for Tissue-Engineered Medical Products (TEMPs) and as Devices for Surgical Implant Applications. West Conshocken, PA: ASTM International; 2011.
25. ASTM Standard F2900-11. Standard Guide for Characterization of Hydrogels used in Regenerative Medicine. West Conshocken, PA: ASTM International; 2011.
26. ASTM Standard F2630-06(2012). Standard Guide for Interpreting Images of Polymeric Tissue Scaffolds. West Conshocken, PA: ASTM International; 2012.
27. ASTM Standard F2150-13. Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products. West Conshocken, PA: ASTM International; 2013.
28. ISO Standards 10993 Series. Biological evaluation of medical devices-Parts 1-20. Geneva, Switzerland: International Organization for Standardization; 2012.
29. Bruinink A, Luginbuehl R,. Evaluation of biocompatibility using in vitro methods: Interpretation and limitations. Adv Biochem Eng Biotechnol 2012; 126: 117-152.
30. Lane JG, Massie JB, Ball ST, Amiel ME, Chen AC, Bae WC, Sah RL, Amiel D,. Follow-up of osteochondral plug transfers in a goat model: a 6-month study. Am J Sports Med 2004; 32: 1440-1450.
31. Naylor JM, Ko V, Rougellis S, Green N, Hackett D, Magrath A, Barnett A, Kim G, White M, Nathan P, Harmer A, Mackey M, Heard R, Yeo AET, Adie S, Harris IA, Mittal R, Cho A,. Is discharge knee range of motion a useful and relevant clinical indicator after total knee replacement? Part 2. J Eval Clin Pract 2012; 18: 652-658.
32. Khanna G, Singh JA, Pomeroy DL, Gioe TJ,. Comparison of patient-reported and clinician-assessed outcomes following total knee arthroplasty. J Bone Joint Surg Am 2011; 93: 1-7.
33. NIST Reference Material 8395. Tissue Engineering Reference Scaffold, 200 Micrometer Strut Spacing, Report of Investigation. Gaithersburg, MD: NIST; 2009.
34. NIST Reference Material 8396. Tissue Engineering Reference Scaffold, 300 Micrometer Strut Spacing, Report of Investigation. Gaithersburg, MD: NIST; 2009.
35. NIST Reference Material 8397. Tissue Engineering Reference Scaffold, 450 Micrometer Strut Spacing, Report of Investigation. Gaithersburg, MD: NIST; 2009.
36. NIST Reference Material 8394. Tissue Engineering Reference Scaffolds for Cell Culture, Report of Investigation. Gaithersburg, MD: NIST; 2012.
37. Viswanathan S, Keating A, Deans R, Hematti P, Prockop D, Stroncek DF, Stacey G, Weiss DJ, Mason C, Rao MS,. Soliciting strategies for developing cell-based reference materials to advance MSC research and clinical translation. Stem Cells Dev 2014; 23: 1157-1167.
38. NIST Standard Reference Material 2910. Calcium Hydroxyapatite, Report of Investigation. Gaithersburg, MD: NIST; 2008.
39. NIST Reference Material 8011. Gold Nanoparticles, Nominal 10 nm Diameter, Report of Investigation. Gaithersburg, MD: NIST; 2012.
40. NIST Reference Material 8012. Gold Nanoparticles, Nominal 30 nm Diameter, Report of Investigation. Gaithersburg, MD: NIST; 2012.
41. NIST Reference Material 8013. Gold Nanoparticles, Nominal 60 nm Diameter, Report of Investigation. Gaithersburg, MD: NIST; 2012.
42. NIST Standard Reference Material 2372. Human DNA Quantitation Standard, Report of Investigation. Gaithersburg, MD: NIST; 2013.
43. NIST Reference Material 8456. Ultra High Molecular Weight Polyethylene, Report of Investigation. Gaithersburg, MD: NIST; 2011.
44. NIST Reference Material 8457. Ultra High Molecular Weight Polyethylene, Report of Investigation. Gaithersburg, MD: NIST; 2012.
45. NIST Standard Reference Material 2374. DNA Sequence Library for External RNA Controls, Report of Investigatio. Gaithersburg, MD: NIST; 2013.
46. Luginbuehl R,. Do's and Don'ts in Characterizing Scaffolds for Tissue Engineering. Fifth World Materials Research Institutes Forum: "Materials Meet Life". Dübendorf, Switzerland EMPA; 2013.
47. University of Maryland Center for Excellence in Regulatory Science and Innovation. College Park, MD: University of Maryland; 2013. Available from URL: http://www.cersi.umd.edu/. Accessed on September 6, 2014.
48. Scopus, Elsevier, Inc., 2014. Available from URL: http://www.scopus.com/. Accessed on September 6, 2014.
49. ASTM Standard F1635-11. ASTM F1635-11 Standard Test Method for In Vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants. West Conshocken, PA: ASTM International; 2011.
50. ASTM Standard D3786-13. Standard Test Method for Bursting Strength of Textile Fabrics-Diaphragm Bursting Strength Tester Method. West Conshocken, PA: ASTM International; 2013.
51. ASTM Standard D5035-11. Standard Test Method for Breaking Force and Elongation of Textile Fabrics (Strip Method). West Conshocken, PA: ASTM International; 2011.
52. ASTM Standard D5587-08. Standard Test Method for Tearing Strength of Fabrics by Trapezoid Procedure. West Conshocken, PA: ASTM International; 2008.
53. ASTM Standard F2027-08. Standard Guide for Characterization and Testing of Raw or Starting Biomaterials for Tissue-Engineered Medical Products. West Conshocken, PA: ASTM International; 2008.
54. ASTM Standard F2211-13. Standard Classification for Tissue Engineered Medical Products (TEMPs). West Conshocken, PA: ASTM International; 2013.
55. ISO Standards 11135 Series. Sterilization of health care products-Ethylene oxide-Parts 1-2. Geneva, Switzerland: International Organization for Standardization; 2008.
56. ASTM Standard F748-06. Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices. West Conshocken, PA: ASTM International; 2010.
57. ISO Standard 10993-5. Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity. Geneva, Switzerland: International Organization for Standardization; 2009.
58. ISO Standard 10993-13. Biological evaluation of medical devices-Part 13: Identification and quantification of degradation products from polymeric medical devices. Geneva, Switzerland: International Organization for Standardization; 2010.
59. ISO Standard 10993-3. Biological evaluation of medical devices-Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity. Geneva, Switzerland: International Organization for Standardization; 2003.
60. ISO Standard 10993-6. Biological evaluation of medical devices-Part 6: Tests for local effects after implantation. Geneva, Switzerland: International Organization for Standardization; 2007.
61. ISO Standard 10993-10. Biological evaluation of medical devices-Part 10: Tests for irritation and skin sensitization. Geneva, Switzerland: International Organization for Standardization; 2010.
62. Jaklenec A, Stamp A, Deweerd E, Sherwin A, Langer R,. Progress in the tissue engineering and stem cell industry are we there yet? Tissue Eng Part B Rev 2012; 18: 155-166.
63. Williams D, O'Donnell P,. The Xi'an Papers, World Summit on Regenerative Medicine. Xi'an, China: Book Conference Solution Co. 2013. Available from URL: http://northheadcomms.com/cn/wp-content/uploads/2013/11/200131031-Xian-Papers-RM-summit.pdf. Accessed on September 6, 2014.
64. Yokoi M, Hattori K, Narikawa K, Ohgushi H, Tadokoro M, Hoshi K, Takato T, Myoui A, Nanno K, Kato Y, Kanawa M, Sugawara K, Kobo T, Ushida T,. Feasibility and limitations of the round robin test for assessment of in vitro chondrogenesis evaluation protocol in a tissue-engineered medical product. J Tissue Eng Regen Med 2012; 6: 550-558.
65. ASTM Standard F2131-02. Standard Test Method for In Vitro Biological Activity of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Using the W-20 Mouse Stromal Cell Line. West Conshocken, PA: ASTM International; 2007.
66. Bravery CA, Carmen J, Fong T, Oprea W, Hoogendoorn KH, Woda J, Burger SR, Rowley JA, Bonyhadi ML, Hof WV,. Potency assay development for cellular therapy products: An ISCT review of the requirements and experiences in the industry. Cytotherapy 2013; 15: 9-19.